Now showing items 1-18 of 18

    • aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis 

      Fan R., Papatheodoridis G., Sun J., Innes H., Toyoda H., Xie Q., Mo S., Sypsa V., Guha I.N., Kumada T., Niu J., Dalekos G., Yasuda S., Barnes E., Lian J., Suri V., Idilman R., Barclay S.T., Dou X., Berg T., Hayes P.C., Flaherty J.F., Zhou Y., Zhang Z., Buti M., Hutchinson S.J., Guo Y., Calleja J.L., Lin L., Zhao L., Chen Y., Janssen H.L.A., Zhu C., Shi L., Tang X., Gaggar A., Wei L., Jia J., Irving W.L., Johnson P.J., Lampertico P., Hou J. (2020)
      Background & Aims: Hepatocellular carcinoma (HCC) is the leading cause of death in patients with chronic hepatitis. In this international collaboration, we sought to develop a global universal HCC risk score to predict the ...
    • Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study 

      Bourne R.R.A., Steinmetz J.D., Saylan M., Mersha A.M., Weldemariam A.H., Wondmeneh T.G., Sreeramareddy C.T., Pinheiro M., Yaseri M., Yu C., Zastrozhin M.S., Zastrozhina A., Zhang Z.-J., Zimsen S.R.M., Yonemoto N., Tsegaye G.W., Vu G.T., Vongpradith A., Renzaho A.M.N., Sorrie M.B., Shaheen A.A., Shiferaw W.S., Skryabin V.Y., Skryabina A.A., Saya G.K., Rahimi-Movaghar V., Shigematsu M., Sahraian M.A., Naderifar H., Sabour S., Rathi P., Sathian B., Miller T.R., Rezapour A., Rawal L., Pham H.Q., Parekh U., Podder V., Onwujekwe O.E., Pasovic M., Otstavnov N., Negash H., Pawar S., Naimzada M.D., Al Montasir A., Ogbo F.A., Owolabi M.O., Pakshir K., Mohammad Y., Moni M.A., Nunez-Samudio V., Mulaw G.F., Naveed M., Maleki S., Michalek I.M., Misra S., Swamy S.N., Mohammed J.A., Flaxman S., Park E.-C., Briant P.S., Meles G.G., Hayat K., Landires I., Kim G.R., Liu X., LeGrand K.E., Taylor H.R., Kunjathur S.M., Khoja T.A.M., Bicer B.K., Khalilov R., Hashi A., Kayode G.A., Carneiro V.L.A., Kavetskyy T., Kosen S., Kulkarni V., Holla R., Kalhor R., Jayaram S., Islam S.M.S., Gilani S.A., Eskandarieh S., Molla M.D., Itumalla R., Farzadfar F., Congdon N.G., Elhabashy H.R., Elayedath R., Couto R.A.S., Dervenis N., Cromwell E.A., Dahlawi S.M.A., Resnikoff S., Casson R.J., Abdoli A., Choi J.-Y.J., Dos Santos F.L.C., Abrha W.A., Nagaraja S.B., Abualhasan A., Adal T.G., Aregawi B.B., Beheshti M., Abu-Gharbieh E., Afshin A., Ahmadieh H., Alemzadeh S.A., Arrigo A., Atnafu D.D., Ashbaugh C., Ashrafi E., Alemayehu W., Alfaar A.S., Alipour V., Anbesu E.W., Androudi S., Arabloo J., Arditi A., Bagli E., Baig A.A., Bärnighausen T.W., Parodi M.B., Bhagavathula A.S., Bhardwaj N., Bhardwaj P., Bhattacharyya K., Bijani A., Bikbov M., Bottone M., Braithwaite T., Bron A.M., Butt Z.A., Cheng C.-Y., Chu D.-T., Cicinelli M.V., Coelho J.M., Dai X., Dana R., Dandona L., Dandona R., Del Monte M.A., Deva J.P., Diaz D., Djalalinia S., Dreer L.E., Ehrlich J.R., Ellwein L.B., Emamian M.H., Fernandes A.G., Fischer F., Friedman D.S., Furtado J.M., Gaidhane S., Gazzard G., Gebremichael B., George R., Ghashghaee A., Golechha M., Hamidi S., Hammond B.R., Hartnett M.E.R., Hartono R.K., Hay S.I., Heidari G., Ho H.C., Househ M., Ibitoye S.E., Ilic I.M., Huang J.J., Ilic M.D., Ingram A.D., Irvani S.S.N., Jha R.P., Kahloun R., Kandel H., Kasa A.S., Kempen J.H., Khairallah M., Khan E.A., Khanna R.C., Khatib M.N., Kim J.E., Kim Y.J., Kisa A., Kisa S., Koyanagi A., Kurmi O.P., Lansingh V.C., Leasher J.L., Leveziel N., Limburg H., Manafi N., Mansouri K., McAlinden C., Mohammadi S.F., Mokdad A.H., Morse A.R., Naderi M., Naidoo K.S., Nangia V., Nguyen H.L.T., Ogundimu K., Olagunju A.T., Panda-Jonas S., Pesudovs K., Peto T., Ur Rahman M.H., Ramulu P.Y., Rawaf D.L., Rawaf S., Reinig N., Robin A.L., Rossetti L., Safi S., Sahebkar A., Samy A.M., Serle J.B., Shaikh M.A., Shen T.T., Shibuya K., Shin J.I., Silva J.C., Silvester A., Singh J.A., Singhal D., Sitorus R.S., Skiadaresi E., Soheili A., Sousa R.A.R.C., Stambolian D., Tadesse E.G., Tahhan N., Tareque Md.I., Topouzis F., Tran B.X., Tsilimbaris M.K., Varma R., Virgili G., Wang N., Wang Y.X., West S.K., Wong T.Y., Jonas J.B., Vos T., GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study (2021)
      Background: Many causes of vision impairment can be prevented or treated. With an ageing global population, the demands for eye health services are increasing. We estimated the prevalence and relative contribution of ...
    • Clinical risk scores for the prediction of incident atrial fibrillation: a modernized review 

      Louka A.M., Tsagkaris C., Stoica A. (2021)
      Atrial fibrillation (AF) is considered the most common sustained arrhythmia. Major cardiovascular risk factors that have been identified to initiate and perpetuate AF include age, sex, arterial hypertension, heart failure, ...
    • Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study 

      Lipnicki D.M., Makkar S.R., Crawford J.D., Thalamuthu A., Kochan N.A., Lima-Costa M.F., Castro-Costa E., Ferri C.P., Brayne C., Stephan B., Llibre-Rodriguez J.J., Llibre-Guerra J.J., Valhuerdi-Cepero A.J., Lipton R.B., Katz M.J., Derby C.A., Ritchie K., Ancelin M.-L., Carrière I., Scarmeas N., Yannakoulia M., Hadjigeorgiou G.M., Lam L., Chan W.-C., Fung A., Guaita A., Vaccaro R., Davin A., Kim K.W., Han J.W., Suh S.W., Riedel-Heller S.G., Roehr S., Pabst A., van Boxtel M., Köhler S., Deckers K., Ganguli M., Jacobsen E.P., Hughes T.F., Anstey K.J., Cherbuin N., Haan M.N., Aiello A.E., Dang K., Kumagai S., Chen T., Narazaki K., Ng T.P., Gao Q., Nyunt M.S.Z., Scazufca M., Brodaty H., Numbers K., Trollor J.N., Meguro K., Yamaguchi S., Ishii H., Lobo A., Lopez-Anton R., Santabárbara J., Leung Y., Lo J.W., Popovic G., Sachdev P.S., Cohort Studies of Memory in an International Consortium (COSMIC) (2019)
      Background: With no effective treatments for cognitive decline or dementia, improving the evidence base for modifiable risk factors is a research priority. This study investigated associations between risk factors and ...
    • Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer’s Disease? 

      Siokas V., Aslanidou P., Aloizou A.-M., Peristeri E., Stamati P., Liampas I., Arseniou S., Drakoulis N., Aschner M., Tsatsakis A., Mitsias P.D., Bogdanos D.P., Hadjigeorgiou G.M., Dardiotis E. (2020)
      Alzheimer’s disease (AD) is a complex genetic disorder. To date, published data have reported conflicting results on the role of CD33 rs3865444 polymorphism in AD. The present study aimed at evaluating the effect of rs3865444 ...
    • Identification of Chromosomal Regions Linked to Diabetic Nephropathy: A Meta-Analysis of Genome-Wide Linkage Scans 

      Tziastoudi M., Stefanidis I., Stravodimos K., Zintzaras E. (2019)
      Aims: Diabetic nephropathy (DN) has become a serious public health problem. Genetic factors are involved in the pathogenesis of DN, but the exact mode of inheritance is still unknown. Genome-wide linkage scans (GWLS) have ...
    • A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease 

      Krüger, R.; Sharma, M.; Riess, O.; Gasser, T.; Van Broeckhoven, C.; Theuns, J.; Aasly, J.; Annesi, G.; Bentivoglio, A. R.; Brice, A.; Djarmati, A.; Elbaz, A.; Farrer, M.; Ferrarese, C.; Gibson, J. M.; Hadjigeorgiou, G. M.; Hattori, N.; Ioannidis, J. P. A.; Jasinska-Myga, B.; Klein, C.; Lambert, J. C.; Lesage, S.; Lin, J. J.; Lynch, T.; Mellick, G. D.; de Nigris, F.; Opala, G.; Prigione, A.; Quattrone, A.; Ross, O. A.; Satake, W.; Silburn, P. A.; Tan, E. K.; Toda, T.; Tomiyama, H.; Wirdefeldt, K.; Wszolek, Z.; Xiromerisiou, G.; Maraganore, D. M. (2011)
      High-profile studies have provided conflicting results regarding the involvement of the Omi/HtrA2 gene in Parkinson's disease (PD) susceptibility. Therefore, we performed a large-scale analysis of the association of common ...
    • Local social engagement, satisfaction, and embeddedness in the Netherlands: which effects matter and for whom? 

      Tselios, V.; Noback, I.; McCann, P.; van Dijk, J. (2015)
      This paper examines to what extent, and for whom, different geographical characteristics affect the levels of local social engagement, satisfaction, and embeddedness in the Netherlands. We employ a uniquely detailed dataset ...
    • Longitudinal Monitoring of Parkinson's Disease in Different Ethnic Cohorts: The DodoNA and LONG-PD Study 

      Markopoulou K., Aasly J., Chung S.J., Dardiotis E., Wirdefeldt K., Premkumar A.P., Schoneburg B., Kartha N., Wilk G., Wei J., Simon K.C., Tideman S., Epshteyn A., Hadsell B., Garduno L., Pham A., Frigerio R., Maraganore D. (2020)
      Background: Different factors influence severity, progression, and outcomes in Parkinson's disease (PD). Lack of standardized clinical assessment limits comparison of outcomes and availability of well-characterized cohorts ...
    • Microbleeds and the Effect of Anticoagulation in Patients with Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial 

      Shoamanesh A., Hart R.G., Connolly S.J., Kasner S.E., Smith E.E., Martí-Fàbregas J., Liu Y.Y., Uchiyama S., Mikulik R., Veltkamp R., O'Donnell M.J., Ntaios G., Muir K.W., Field T.S., Santo G.C., Olavarria V., Mundl H., Lutsep H., Berkowitz S.D., Sharma M. (2021)
      Importance: The reported associations of cerebral microbleeds with recurrent stroke and intracerebral hemorrhage have raised concerns regarding antithrombotic treatment in patients with a history of stroke and microbleeds ...
    • Mutation profile of KRAS and BRAF genes in patients with colorectal cancer: Association with morphological and prognostic criteria 

      Samara M., Kapatou K., Ioannou M., Kostopoulou Ε., Papamichali R., Papandreou C., Athanasiadis A., Koukoulis G. (2015)
      KRAS and BRAF mutations are well-recognized molecular alterations during colorectal carcinogenesis, but there is little agreement on their effect on tumor characteristics. Therefore, we aimed to evaluate the distribution ...
    • Normal ranges of left atrial volumes and ejection fraction by 3D echocardiography in adults: a systematic review and meta-analysis 

      Figliozzi S., Georgiopoulos G., Pateras K., Sianis A., Previtero M., Tondi L., Petropoulos Ι., Bragato R.M., Papachristidis A., Condorelli G., Takeuchi M. (2022)
      Increased sizes and dysfunction of the left atrium have been related to adverse outcomes. 3D-echocardiography is more accurate than 2D-echocardiography in estimating LA volumes and ejection fraction. However, the use of ...
    • Regional perspectives on the neolithic anthropomorphic imagery of northern Greece 

      Nanoglou, S. (2006)
      This article considers the ways in which regional differences in material culture are constituted and maintained, using the example of Neolithic anthropomorphic figures from northern Greece. The aim of the paper is to offer ...
    • Resilience profiles across context: A latent profile analysis in a German, Greek, and Swiss sample of adolescents 

      Janousch C., Anyan F., Kassis W., Morote R., Hjemdal O., Sidler P., Graf U., Rietz C., Chouvati R., Govaris C. (2022)
      The present study investigated resilience profiles (based on levels of symptoms of anxiety and depression and five dimensions of protective factors) of 1,160 students from Germany (n = 346, 46.0% females, Mage = 12.77, ...
    • The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis 

      Leucht S., Chaimani A., Krause M., Schneider-Thoma J., Wang D., Dong S., Samara M., Peter N., Huhn M., Priller J., Davis J.M. (2022)
      Background: As comparatively few trials in subgroups of patients with schizophrenia have been done, clinicians need to know whether they can rely on the results of randomised controlled trials (RCTs) in the general population ...
    • Serpin family E member 1 tag single-nucleotide polymorphisms in patients with diabetic nephropathy: An association study and meta-analysis using a genetic model-free approach 

      Tziastoudi M., Dardiotis E., Pissas G., Filippidis G., Golfinopoulos S., Siokas V., Tachmitzi S.V., Eleftheriadis T., Hadjigeorgiou G.M., Tsironi E., Stefanidis I. (2021)
      Background: Many lines of evidence highlight the genetic contribution on the development of diabetic nephropathy (DN). One of the studied genes is SERPINE1 whose the role in the risk of developing DN remains questionable. ...
    • Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers 

      Bossen L., Gerussi A., Lygoura V., Mells G.F., Carbone M., Invernizzi P. (2018)
      Autoimmune liver diseases (AILDs) are complex conditions, which arise from the interaction between a genetic susceptibility and unknown environmental triggers. They represent a relevant cause of liver failure and liver ...
    • A systematic review and meta-analysis of pharmacogenetic studies in patients with chronic kidney disease 

      Tziastoudi M., Pissas G., Raptis G., Cholevas C., Eleftheriadis T., Dounousi E., Stefanidis I., Theoharides T.C. (2021)
      Chronic kidney disease (CKD) is an important global public health problem due to its high prevalence and morbidity. Although the treatment of nephrology patients has changed considerably, ineffectiveness and side effects ...